Furthermore, low MEG8 levels in endothelial cells are known to impair endothelial function, which in turn, in addition to promoting VTE, also plays a role in cancer by amplifying the tumour inflammatory signalling and consequently promoting tumorigenesis [85,97,98]. This evidence concerns the gene MEG8 and cancer.